ImmuPharma PLC (AIM:IMM) will attend the Bio-Europe Spring Conference in Milan from 17-19 March. CEO Tim McCarthy, COO Dr Tim Franklin, and Dr Sebastien Goudreau, head of its R&D subsidiary, will represent the company. The event is a key networking opportunity, bringing together over 3,700 executives for more than 20,000 meetings. ImmuPharma aims to showcase recent insights into the mechanism of action of its P140 technology platform and engage with potential partners in the biotech and pharmaceutical industries.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com